1.09
Precedente Chiudi:
$1.18
Aprire:
$1.1
Volume 24 ore:
763.49K
Relative Volume:
1.09
Capitalizzazione di mercato:
$108.99M
Reddito:
$100.56M
Utile/perdita netta:
$-119.05M
Rapporto P/E:
-0.8862
EPS:
-1.23
Flusso di cassa netto:
$-231.16M
1 W Prestazione:
-18.05%
1M Prestazione:
-22.70%
6M Prestazione:
-74.17%
1 anno Prestazione:
-81.49%
Alector Inc Stock (ALEC) Company Profile
Nome
Alector Inc
Settore
Industria
Telefono
415-231-5660
Indirizzo
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Confronta ALEC con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ALEC
Alector Inc
|
1.09 | 108.99M | 100.56M | -119.05M | -231.16M | -1.23 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 125.55B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 67.78B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
590.06 | 36.24B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.99B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
264.32 | 28.77B | 3.81B | -644.79M | -669.77M | -6.24 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-17 | Downgrade | Mizuho | Outperform → Neutral |
2024-12-16 | Downgrade | Stifel | Buy → Hold |
2024-12-04 | Downgrade | BofA Securities | Neutral → Underperform |
2024-11-29 | Reiterato | H.C. Wainwright | Buy |
2024-11-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2023-12-14 | Aggiornamento | Stifel | Hold → Buy |
2023-12-12 | Iniziato | Deutsche Bank | Buy |
2023-09-25 | Iniziato | Goldman | Sell |
2023-09-22 | Iniziato | Cantor Fitzgerald | Overweight |
2023-01-06 | Downgrade | BofA Securities | Buy → Neutral |
2022-09-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2022-07-07 | Iniziato | Mizuho | Buy |
2022-04-13 | Iniziato | Goldman | Sell |
2022-03-08 | Downgrade | Stifel | Buy → Hold |
2021-09-27 | Iniziato | William Blair | Outperform |
2021-01-15 | Ripresa | BofA Securities | Buy |
2020-06-24 | Iniziato | H.C. Wainwright | Buy |
2020-04-28 | Iniziato | Goldman | Buy |
2020-03-06 | Iniziato | Citigroup | Buy |
2020-02-27 | Iniziato | Barclays | Overweight |
2020-02-19 | Iniziato | Stifel | Buy |
2019-11-21 | Iniziato | BTIG Research | Buy |
2019-03-04 | Iniziato | Barclays | Overweight |
2019-03-04 | Iniziato | BofA/Merrill | Buy |
2019-03-04 | Iniziato | Morgan Stanley | Overweight |
2019-03-04 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Alector Inc Borsa (ALEC) Ultime notizie
Frontotemporal Dementia Pipeline 2025: Key Companies, MOA, - openPR.com
Brokerages Set Alector, Inc. (NASDAQ:ALEC) Price Target at $3.50 - Defense World
Alector stock hits 52-week low at $1.24 amid market challenges - Investing.com
Charles Schwab Investment Management Inc. Reduces Stock Position in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector, Inc. (NASDAQ:ALEC) Shares Sold by Charles Schwab Investment Management Inc. - The AM Reporter
Alector Announces Resignation of Chief Medical Officer - TipRanks
Alector Appoints New Chief Medical Officer - MarketScreener
Alector Provides Executive Leadership Update - The Manila Times
Alector Names Neurology Expert as CMO Amid Crucial Phase 3 Dementia Trial - Stock Titan
Alector Cuts Staff Again, This Time Laying Off 13% of Workforce - BioSpace
Alector, Inc. (NASDAQ:ALEC) Not Doing Enough For Some Investors As Its Shares Slump 26% - simplywall.st
Alector stock hits 52-week low at $1.29 amid sharp annual decline - Investing.com Australia
Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments By Investing.com - Investing.com South Africa
Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments - Investing.com
Alector: Q4 Of 2025 FTD-GRN Treatment Data Is Important Inflection Point (NASDAQ:ALEC) - Seeking Alpha
Mizuho’s latest rating for ALEC stock - Knox Daily
Alector at Leerink Global Healthcare Conference: Strategic Advances in Neurodegeneration - Investing.com India
Alector announces workforce reduction to cut costs By Investing.com - Investing.com Australia
Alector announces workforce reduction to cut costs - Investing.com
Alector to Cut 13% of Workforce - MarketWatch
Have Alector Insiders Been Selling Stock? - simplywall.st
Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Consensus Target Price from Analysts - Defense World
Alector assumed with an Underweight at Morgan Stanley - TipRanks
Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies - Investing.com India
Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies By Investing.com - Investing.com UK
Alector Executives Sell Shares to Satisfy Tax Obligations - TradingView
Alector stock hits 52-week low at $1.54 amid sharp annual decline - Investing.com Australia
William Blair Predicts Alector’s Q1 Earnings (NASDAQ:ALEC) - The AM Reporter
Alector stock hits 52-week low at $1.54 amid sharp annual decline By Investing.com - Investing.com South Africa
Research Analysts Set Expectations for Alector Q1 Earnings - Defense World
Earnings Update: Alector, Inc. (NASDAQ:ALEC) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St
Alector (NASDAQ:ALEC) Receives "Buy" Rating from HC Wainwright - MarketBeat
Alector Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
Alector’s Earnings Call: Progress Amid Challenges - TipRanks
Alector (NASDAQ:ALEC) Releases Earnings Results, Beats Expectations By $0.59 EPS - MarketBeat
Alector Inc (ALEC) Shares Up Despite Recent Market Volatility - The News Heater
Alector, Inc. (NASDAQ:ALEC) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Alector Inc Q4 2024 sees cautious market reaction By Investing.com - Investing.com South Africa
Alector Inc (ALEC) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising Clinical Advances - GuruFocus.com
Alector: Q4 Earnings Snapshot - mySA
The Bold Bet on Brain Health: Alector’s Race Against Time in Neurodegenerative Research - Smartphone Magazine
Alector Inc (NASDAQ:ALEC): The Biotech Pioneering New Frontiers in Neurodegenerative Diseases - Jomfruland.net
Alector beats Q4 estimates, shares edge higher By Investing.com - Investing.com South Africa
Alector Inc (ALEC) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising ... - Yahoo Finance
Alector, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Alector’s 2024 Financial Results and Clinical Advancements - TipRanks
Alector Inc Azioni (ALEC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):